E2F1 and hepatocellular carcinoma: Some studies have shown that IGF2BP3 may regulate the cell cycle by controlling the stability and transcription of the transcriptional activator E2F1 (64), promote the proliferation, colony formation, and invasion of HCC cells, and is expected to be a novel marker for predicting ferroptosis, HCC immune response and prognosis (65).